Cite

HARVARD Citation

    Ashina, M. et al. (2022). Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2. Cephalalgia. pp. 696-704. [Online]. 
  
Back to record